Trial Profile
A randomized, placebo-controlled study to evaluate safety, tolerance, pharmacokinetics and antiviral activity of amdoxovir and zidovudine in untreated HIV-1 infected subjects currently untreated
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Amdoxovir (Primary) ; Zidovudine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors RFS Pharma
- 28 Dec 2009 Pharmacokinetic results published in Antimicrobial Agents and Chemotherapy.
- 09 Mar 2007 New trial record.